ROCHESTER, MN — Duration of initial disease response remains a strong prognostic factor in multiple myeloma (MM), especially for upfront autologous hematopoietic cell transplant (AHCT) recipients. A study in the journal Leukemia hypothesized that new drug...
VA Patients Lack Testing to Optimize CLL Treatment
SALT LAKE CITY — The presence of deletion 17p (del17), determined by chromosome analysis and/or fluorescence in situ hybridization (FISH), is a strong negative prognostic marker in chronic lymphocytic leukemia (CLL), according to a report in the Journal of Clinical Oncology.1
Laparoscopic, Robotic Surgeries Equivalent for Pancreatic Cancer
Pancreatic cancer patients increasingly are receiving minimally invasive pancreaticoduodenectomy (MIPD).
